ALZAMEND NEURO INC (ALZN)
US02262M4078 - Common Stock
| TTM (2023-10-31) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | 2020 (2020-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.16M | -14.88M | -12.36M | -5.05M | -4.41M | |||
| Depreciation Amortization | 35.37K | 20.00K | 0.00 | N/A | N/A | |||
| Change In Working Capital | 3.59M | 2.35M | 1.33M | -150.00K | -300.00K | |||
| Other non cash items | 2.69M | 3.58M | 4.42M | 2.49M | 2.36M | |||
| OPERATING CASH FLOW | -8.85M | -8.92M | -6.61M | -2.71M | -2.35M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -110.00K | N/A | N/A | |||
| Other Investing Activity | N/A | N/A | 0.00 | 100.00K | 110.00K | |||
| INVESTING CASH FLOW | N/A | 0.00 | -110.00K | 100.00K | 110.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 400.00K | N/A | |||
| Stock Issued/Repurchased | N/A | 0.00 | 18.91M | 2.10M | 2.29M | |||
| Other Financing Activity | N/A | 0.00 | -60.00K | 1.95M | 0.00 | |||
| FINANCING CASH FLOW | N/A | 0.00 | 18.85M | 4.45M | 2.29M | |||
| CHANGE IN CASH | -8.98M | -8.92M | 12.13M | 1.84M | 50.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.85M | -8.92M | -6.61M | -2.71M | -2.35M | |||
| Capital Expenditure | N/A | 0.00 | -110.00K | N/A | N/A | |||
| FREE CASH FLOW | -9.00M | -8.92M | -6.72M | -2.71M | -2.35M | |||
All data in USD